that's why we have a stock market and venture money and my one simple answer is the patents----perhaps premature until FDA approval but i am positive of my value thoughts when the certficate comes in the mail----perhaps that is whats holding it all up or as the recent US press clearly indicates there have been conversations already and AVH in my opinion goes higher in value( not necessarily stock price )every day that ticks off the FDA clock. And the quantity of discussions will tick north as well within this time line.
This is a big league deal or i wouldnt be feeling the way i am. When you see this stock rise into the 30s and 40s that may very well answer your question or validate my thoughts but when that happens---thats the fun of it all i guess!
When you own a certificate of validation on a product and patent that could be way up in the billions that patent is worth billions just for the rights associated with that ownership. And the sales at that time could literally and figuratively be zero----hows that for an irony and its all about how the presentation evolves when the clock ticks.
All you have to do is look at the evolution of companies like Amgen and Biogen and for that matter what are Mesoblasts current sales if any to drill the point home and they have a 2Billion market cap and probably will be worth more in the future. Its all show biz mate and neither of us really know how it all evolves in the end but the discounted value of that future patent in my opinion spells a dollar today and we will know if i am right by the end of the year---if it wasnt for something stupid and idiotic like Clinical cell origins and no prior prejudices aside i am positive i would have already been correct by now and it could be overpriced north of a dollar today----thank you clinical cell for the opportunity you created---otherwise we wouldnt have gotten in so cheap with all due respect to yes---DVEous
- Forums
- ASX - By Stock
- AVH
- what is the real value
AVH
avita medical inc.
Add to My Watchlist
2.74%
!
$1.69

what is the real value, page-8
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.69 |
Change
0.045(2.74%) |
Mkt cap ! $117.5M |
Open | High | Low | Value | Volume |
$1.70 | $1.73 | $1.67 | $457.4K | 270.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 25952 | $1.68 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.71 | 5000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1000 | 1.675 |
2 | 13000 | 1.670 |
1 | 3000 | 1.650 |
1 | 12487 | 1.645 |
1 | 59185 | 1.640 |
Price($) | Vol. | No. |
---|---|---|
1.705 | 5000 | 1 |
1.720 | 580 | 2 |
1.730 | 3000 | 1 |
1.745 | 1000 | 1 |
1.750 | 14781 | 3 |
Last trade - 16.10pm 04/07/2025 (20 minute delay) ? |
Featured News
AVH (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online